1.Recent advances in the management of hepatocellular carcinoma.
Journal of the Korean Medical Association 2013;56(11):946-947
No abstract available.
Carcinoma, Hepatocellular*
2.Analysis of DNA Ploidy Pattern of Hepatocellular Carcinoma with Comparison between Flow Cytometric and Image Cytometric Study.
Sung Sook KIM ; Seok Gun PARK ; Dong Sun HAN ; Man Ha HUH
Korean Journal of Pathology 1992;26(1):1-9
Fifty cases of hepatocellularcarcinoma were studied using retrospective flow cytometric(FCM) and image cytometric(ICM) DNA analysis to determine the prevalence of aneuploid cell population and whether they were associated with any particular clinico-pathologic findings. At the same time, we compared the difference between FCM and ICM. The materials were prepared from 50 micrometer cut of paraffin embedded blocks. The DNA modal values, which could be defined in 42 cases by FCM with 74% aneuploidy and in 50 cases by ICM with 76% aneuploidy. So 95% of the cases had concordant DNA ploidy results by both techniques of FCM and ICM. Abnormal DNA pattern was correlated with age(<50), presence of cirrhosis, pathologic grade and some pathologic types(p<0.05), but was not correlated with presence of HBsAg, sex, alphafeto protein, and alcohol history(p>0.05). Also we found that ICM technique was easier to perform and interprete.
Carcinoma, Hepatocellular
3.The Tissue Expression of HBsAg and HBcAg in Hepatocellular Carcinoma and Peritumoral Liver.
Jee Young HAN ; Woo Hee JUNG ; Chae Yoon CHON ; Chan Il PARK
Korean Journal of Pathology 1993;27(4):371-378
To evaluate the tissue expression rate and pattenr of HBsAg and HBcAg in tumors and peritumoral livers, an immunohistochemical study was undertaken on 47 surgically resected hepatocellular carcinomas(HCCs). The results are as follows. 1. Patient's sera were positive for HBsAg in 40 cases(85.1%). In the remaining 7 cases, the tumor and peritumoral liver expressed neither HBcAg nor HbSaG, suggesting that they were caused by other etiologies than hepatitis B virus. 2. The peritumoral liver had HBsAg and HBcAg in 95.0% and 27.5% among the 40 cases, respectively. But the tumor expressed HBsAg in 50.0% and HBcAg in none. 3. The expression of HBsAg within the tumor and both HBsAg and HBcAg in the peritumoral liver tended to be more frequent in the pretreated cases before surgery. 4. Edmondson-Steiner grade IV tumors revealed a lower expression rate of HBsAg than the low grade tumors(p<0.05). Incases with cirrhosis at peritumoral tissues, HBcAg was less frequently found than in those without cirrhosis. The majority of tissue HBsAg and HBcAg was represented as groups of positive cells. These results suggest that, during the development and progression of HCCs, the HBcAg containing cells are repeatedly removed and the HBcAg negative cells are selected, because cellular expression of HBcAg is the target of host immune response.
Carcinoma, Hepatocellular
4.Dynamic CT Finding of Pelioid HCC; Case Report.
Rak Chae SON ; Jae Woon KIM ; Jae Chun CHANG
Yeungnam University Journal of Medicine 2010;27(2):146-149
Pelioid hepatocellular carcinoma (HCC), a type of atypical HCC, is a rare histologic type of HCC. The radiologic findings of the pelioid HCC is differ from the typical type of HCC. To our knowledge, this case report is the second literature to show the enhancing features of a pelioid HCC on dynamic computed tomography (CT). Here we describe the dynamic CT findings in a case of surgically confirmed pelioid HCC.
Carcinoma, Hepatocellular
5.Early Hepatocellular Carcinoma.
Journal of the Korean Medical Association 2000;43(6):547-553
No abstract available.
Carcinoma, Hepatocellular*
6.PIVKA-II ; The significance as a new numor marker for hepatocellular carcinoma.
Seong Ho CHOI ; Young Min SHIN ; Sang Hyun KIM ; Seung Keun PARK ; Hun Jig LEE ; Dae Han KANG ; Mong CHO ; Ung Suk YANG ; Han Gyu MOON
Korean Journal of Medicine 1993;45(1):69-76
No abstract available.
Carcinoma, Hepatocellular*
7.Liver Cirrhosis: Etiological diagnosis and morphological characteristics of 369 biopsy-proven cases.
Eun Kyung HAN ; Chanil PARK ; Sang In LEE
Korean Journal of Pathology 1990;24(4):412-422
To pursue a desirable format for the pathological diagnosis of liver cirrhosis, the authors attempted to classify 369 biopsy-proven cirrhosis on the basis of etiology and made effort to find out the morphological characteristics of each category. About 735 of total cases were HBsAg seropositive postnecrotic cirrhosis. Alcholic cirrhosis ws the second most frequent type, although accounted only 6.8%. In about 15%, the etiology was not known. Excluding the congenital biliary atresia, chronic biliary obstruction appeared to be a rare cause of cirrhosis among these biopsied cases. Of the HBsAg positive postnecrotic cirrhosis, the eAg seropositive cases tended to be micronodular and to show a higher necroinflammatory activity, in contrast to eAg seronegative cases and those complicated by hepatocellular carcinoma (HCC), suggesting that the loss of eAg is followed by a decrease of the destructive activity, active regeneration of hepatocytes and finally the development of HCC. alcoholic cirrhosis was micronodular in 64% and revealed histologic evidences of alcoholic liver disease in most cases. The results indicate that etiological diagnosis can be made in most cases of cirrhosis by the morphological characteristics and the precise clinical informations, including those on the NANB virus and the inborn error of metabolism, and that the pathological diagnosis should be more comprehensive, implicating the etiology, the nodular size and the necroinflammatory activity.
Carcinoma, Hepatocellular
8.Treatment of Hepatocellular carcinoma.
Korean Journal of Medicine 2001;61(6):583-589
No abstract available.
Carcinoma, Hepatocellular*
9.Small hepatocellular carcinoma; treatment with subsegmental intrahepatic arterial injection of radioliodinated fatty acid ester.
Hyung Sik YOO ; Jong Tae LEE ; Ki Whang KIM ; Chang Yun PARK ; Byung Soo KIM ; Heung Jai CHOI ; Kyong Sik LEE ; Chan Il PARK
Journal of the Korean Cancer Association 1992;24(3):411-421
No abstract available.
Carcinoma, Hepatocellular*
10.Clinical evaluation of therapeutic trial for unresectable hepatocellular carcinoma.
Hung Jun KIM ; Hee Jung WANG ; Hyucksang LEE
Journal of the Korean Surgical Society 1991;40(5):601-610
No abstract available.
Carcinoma, Hepatocellular*